human AM/AMBP-1 (TheraSource)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namehuman AM/AMBP-1 (TheraSource)
Drug Alias Namehuman adrenomedullin/adrenomedullin binding protein-1 (TheraSource)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAdrenomedullin receptor agonists
TargetsAdrenomedullin receptor
Therapy Area/IndicationsIschemiaShock, HemorrhagicReperfusion Injury +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheraSource LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheraSource LLC
Active IndicationsN/A
Inactive IndicationsIschemiaShock, HemorrhagicReperfusion Injury +[4] 

Other Information

ATC CodeN/A
Related LinksN/A